World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
14613
World Ranking
3131
National Ranking
1465

Overview

Mary Lou Clements is affiliated with Johns Hopkins University in the United States. Their academic work is connected to this institution, reflecting an involvement in research or teaching activities at this university.

There is no available information on recent papers, coauthors, or specific publication venues linked to Mary Lou Clements. Likewise, details regarding any book publications, main fields of study, subfields, or main topics of research are not documented.

No records exist relating to awards or honors received by Mary Lou Clements, and they are not reported as deceased.

Despite the limited data on specific research outputs or scientific contributions, the association with Johns Hopkins University suggests engagement in academic and research environments within the United States.

Best Publications

  • Experimental Campylobacter jejuni Infection in Humans

    Robert E. Black;Myron M. Levine;Myron M. Levine;Mary Lou Clements;Mary Lou Clements;Timothy P. Hughes;Timothy P. Hughes

  • New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

    M M Levine;J B Kaper;R E Black;M L Clements

  • The Diarrheal Response of Humans to Some Classic Serotypes of Enteropathogenic Escherichia coli is Dependent on a Plasmid Encoding an Enteroadhesiveness Factor

    Myron M. Levine;James P. Nataro;Helge Karch;Mary M. Baldini

  • Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus.

    M L Clements;R F Betts;E L Tierney;B R Murphy

  • Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1

    J R Mascola;S W Snyder;O S Weislow;S M Belay

  • Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.

    M M Levine;J B Kaper;D Herrington;G Losonsky

  • Duration of Infection-Derived Immunity to Cholera

    M. M. Levine;R. E. Black;M. L. Clements;L. Cisneros

  • Clade B-Based HIV-1 Vaccines Elicit Cross-Clade Cytotoxic T Lymphocyte Reactivities in Uninfected Volunteers

    Guido Ferrari;Will Humphrey;M. Juliana McElrath;Jean–Louis Excler

  • Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans.

    M M Levine;P Ristaino;G Marley;C Smyth

  • Human immune responses to influenza virus vaccines administered by systemic or mucosal routes.

    Z. Moldoveanu;M.L. Clements;S.J. Prince;B.R. Murphy

  • Prevention of Shigellosis by a Salmonella typhi-Shigella sonnei Bivalent Vaccine

    Robert E. Black;Robert E. Black;Myron M. Levine;Myron M. Levine;Mary Lou Clements;Mary Lou Clements;Genevieve Losonsky;Genevieve Losonsky

  • Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.

    M H Snyder;R F Betts;D DeBorde;E L Tierney

  • The systemic and mucosal immune response of humans to influenza A virus.

    B. R. Murphy;M. L. Clements

  • Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.

    R E Black;M M Levine;M L Clements;C R Young

  • Augmentation of Human Immunodeficiency Virus Type 1 Neutralizing Antibody by Priming with gp160 Recombinant Vaccinia and Boosting with gp160 in Vaccinia-Naive Adults

    Barney S. Graham;Thomas J. Matthews;Robert B. Belshe;Mary Lou Clements

  • The Safety and Immunogenicity of a Human Immunodeficiency Virus Type 1 (HIV-1) Recombinant gp160 Candidate Vaccine in Humans

    Raphael Dolin;Barney S. Graham;Stephen B. Greenberg;Carol O. Tacket

  • The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine.

    Paolo G. Miotti;Kenrad E. Nelson;Gina A. Dallabetta;Homayoon Farzadegan

  • Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine

    Rimas J. Orentas;James E K Hildreth;Eugene Obah;Michael J Polydefkis

  • Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network.

    Graham Bs;Belshe Rb;Clements Ml;Dolin R

  • Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum.

    D K Wagner;M L Clements;C B Reimer;M Snyder

Frequent Co-Authors

Myron M. Levine
Myron M. Levine University of Maryland, Baltimore
Robert B. Belshe
Robert B. Belshe Saint Louis University
Barney S. Graham
Barney S. Graham Morehouse School of Medicine
Raphael Dolin
Raphael Dolin Beth Israel Deaconess Medical Center
Michael C. Keefer
Michael C. Keefer University of Rochester
Peter F. Wright
Peter F. Wright Dartmouth College
Robert F. Betts
Robert F. Betts University of Rochester
Ruth A. Karron
Ruth A. Karron Johns Hopkins University
Brian R. Murphy
Brian R. Murphy National Institute of Allergy and Infectious Diseases
Mark C. Steinhoff
Mark C. Steinhoff Cincinnati Children's Hospital Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, expanding educational credentials through related healthcare degrees can open diverse career pathways. Many professionals choose to enhance their clinical skills with programs like the accelerated FNP, which fast-tracks registered nurses into family nurse practitioner roles, combining patient care with a deeper understanding of immune-related health issues.

Non-nurses looking to enter this growing field might explore online ABSN programs for non nurses. These programs are designed to transition students into nursing quickly, building a foundation that supports specialized study areas like immunology and infectious diseases.

For individuals seeking faster entry into nursing, considering the easiest ABSN to get into can be a strategic step. These programs often have flexible admission criteria, enabling passionate students to advance their education without extensive delays.

Alternatively, starting with practical nursing roles through the easiest LPN programs to get into offers a quick pathway into patient care. LPNs provide essential support in clinical settings, often collaborating with immunology experts and contributing valuable hands-on experience.

Best Scientists Citing Mary Lou Clements

Recently Published Articles